Dr. Ian Anderson, M.D.
Claim this profileProvidence Medical Foundation
About Ian Anderson, M.D.
Education:
Obtained an MD from the University of Washington School of Medicine in 2015.
Completed a residency in Internal Medicine at Providence St. Vincent Medical Center, Portland, Oregon (2015-2018).
Board Certified in Internal Medicine by the American Board of Internal Medicine.
Experience:
Practices as an internal medicine physician at Providence Medical Foundation.
Area of expertise
Lung Cancer
Ian Anderson, M.D. has run 13 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Ian Anderson, M.D. has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Providence Medical Foundation
St Joseph Heritage Healthcare
Clinical Trials Ian Anderson, M.D. is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting
1 award
Phase 2
11 criteria
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting
2 awards
Phase 3
More about Ian Anderson, M.D.
Clinical Trial Related
5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Ian Anderson, M.D. has experience with
- Carboplatin
- Pembrolizumab
- Disitamab Vedotin
- Cisplatin
- Gemcitabine
- PRO1184
Breakdown of trials Ian Anderson, M.D. has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ian Anderson, M.D. specialize in?
Ian Anderson, M.D. focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ian Anderson, M.D. currently recruiting for clinical trials?
Yes, Ian Anderson, M.D. is currently recruiting for 6 clinical trials in Santa Rosa California. If you're interested in participating, you should apply.
Are there any treatments that Ian Anderson, M.D. has studied deeply?
Yes, Ian Anderson, M.D. has studied treatments such as Carboplatin, Pembrolizumab, Disitamab Vedotin.
What is the best way to schedule an appointment with Ian Anderson, M.D.?
Apply for one of the trials that Ian Anderson, M.D. is conducting.
What is the office address of Ian Anderson, M.D.?
The office of Ian Anderson, M.D. is located at: Providence Medical Foundation, Santa Rosa, California 95403 United States. This is the address for their practice at the Providence Medical Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.